The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
European journal of endocrinology / European Federation of Endocrine Societies 2014 Jan 170 (1): 55-61.
Vannucchi Guia, Covelli Danila, Campi Irene, Origo Daniele, Currò Nicola, Cirello Valentina, Dazzi Davide, Beck-Peccoz Paolo, Salvi Mar
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 20, 2019
- Content source: